Boston Scientific, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 12.5%. BSX's earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 7.5%. Boston Scientific's shares have rallied 46.3% against the industry's 1.8% decline in the past year. Veeva Systems Inc. (VEEV) recently announced that it is partnering with Vita Global Sciences. The partnership aims to modernize the latter's clinical data management processes and improve colla ...